Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 101 participants.
Also called NCT02565693
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 101 participants
- Sponsor
- Registry
-
NCT02565693 -
2014-000112-33 -
U1111-1154-5474
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Netherlands
- Registry status
- Completed
Technical summary
Registry record NCT02565693. Randomized; single masking; primary purpose treatment. Start 2014-09 (actual); primary completion 2021-01-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation
- Acronym
- APACHE-AF
- Condition
- Cerebral Hemorrhage
- Condition
- Atrial Fibrillation
- Intervention (Drug)
- Apixaban
- Intervention (Drug)
- Aspirin
- Intervention (Drug)
- Carbasalate calcium
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- Dipyridamole
- Intervention (Other)
- No antithrombotic treatment
- Lead sponsor
- UMC Utrecht
- Collaborator
- Dutch Heart Foundation
- Collaborator
- ZonMw: The Netherlands Organisation for Health Research and Development
Record details
- Record id
cardio:ct-nct02565693- Content hash
6270f1c994093a546ed84b51960aebec2d69ac1103c05853021ed4d949e80d07